Logo image of 1ANTM.MI

ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis

BIT:1ANTM - Euronext Milan - US0367521038 - Common Stock - Currency: EUR

380.1  +33.9 (+9.79%)

Fundamental Rating

4

1ANTM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 24 industry peers in the Health Care Providers & Services industry. While 1ANTM is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, 1ANTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year 1ANTM was profitable.
1ANTM had a positive operating cash flow in the past year.
Each year in the past 5 years 1ANTM has been profitable.
Each year in the past 5 years 1ANTM had a positive operating cash flow.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of 1ANTM (5.12%) is better than 82.14% of its industry peers.
1ANTM has a better Return On Equity (14.47%) than 75.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.52%, 1ANTM is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 6.16%.
Industry RankSector Rank
ROA 5.12%
ROE 14.47%
ROIC 6.52%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.38%, 1ANTM is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ANTM has declined.
1ANTM has a Operating Margin (5.18%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 1ANTM has declined.
Industry RankSector Rank
OM 5.18%
PM (TTM) 3.38%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ANTM is destroying value.
The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
Compared to 5 years ago, 1ANTM has less shares outstanding
1ANTM has a worse debt/assets ratio than last year.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1ANTM has a debt to FCF ratio of 6.96. This is a slightly negative value and a sign of low solvency as 1ANTM would need 6.96 years to pay back of all of its debts.
1ANTM has a better Debt to FCF ratio (6.96) than 64.29% of its industry peers.
1ANTM has a Debt/Equity ratio of 0.72. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
1ANTM's Debt to Equity ratio of 0.72 is fine compared to the rest of the industry. 1ANTM outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.96
Altman-Z N/A
ROIC/WACC0.83
WACC7.89%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for 1ANTM have decreased by -0.42% in the last year.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
1ANTM shows a small growth in Revenue. In the last year, the Revenue has grown by 3.19%.
1ANTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.49%

3.2 Future

The Earnings Per Share is expected to grow by 12.36% on average over the next years. This is quite good.
Based on estimates for the next years, 1ANTM will show a small growth in Revenue. The Revenue will grow by 7.14% on average per year.
EPS Next Y4.82%
EPS Next 2Y9.47%
EPS Next 3Y11.73%
EPS Next 5Y12.36%
Revenue Next Year10.19%
Revenue Next 2Y8.79%
Revenue Next 3Y8.77%
Revenue Next 5Y7.14%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

3

4. Valuation

4.1 Price/Earnings Ratio

1ANTM is valuated correctly with a Price/Earnings ratio of 13.10.
Compared to the rest of the industry, the Price/Earnings ratio of 1ANTM indicates a somewhat cheap valuation: 1ANTM is cheaper than 67.86% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 1ANTM to the average of the S&P500 Index (27.30), we can say 1ANTM is valued rather cheaply.
A Price/Forward Earnings ratio of 12.49 indicates a correct valuation of 1ANTM.
1ANTM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1ANTM is cheaper than 64.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, 1ANTM is valued a bit cheaper.
Industry RankSector Rank
PE 13.1
Fwd PE 12.49
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ANTM is valued a bit more expensive than 60.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1ANTM is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 21.79
EV/EBITDA 11.41
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.72
PEG (5Y)1.17
EPS Next 2Y9.47%
EPS Next 3Y11.73%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.61%, 1ANTM has a reasonable but not impressive dividend return.
1ANTM's Dividend Yield is comparable with the industry average which is at 2.80.
Compared to the average S&P500 Dividend Yield of 2.35, 1ANTM is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

25.22% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP25.22%
EPS Next 2Y9.47%
EPS Next 3Y11.73%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

BIT:1ANTM (4/7/2025, 7:00:00 PM)

380.1

+33.9 (+9.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-23 2025-01-23/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners91.45%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap86.05B
Analysts79.26
Price Target483.14 (27.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend5.76
Dividend Growth(5Y)15.34%
DP25.22%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.02%
Min EPS beat(2)-14.2%
Max EPS beat(2)0.17%
EPS beat(4)3
Avg EPS beat(4)-3.47%
Min EPS beat(4)-14.2%
Max EPS beat(4)0.17%
EPS beat(8)6
Avg EPS beat(8)-0.87%
EPS beat(12)9
Avg EPS beat(12)0.38%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)2.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.39%
PT rev (1m)0%
PT rev (3m)-8.32%
EPS NQ rev (1m)4.87%
EPS NQ rev (3m)10.45%
EPS NY rev (1m)0.2%
EPS NY rev (3m)-2.13%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)1.71%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)2.43%
Valuation
Industry RankSector Rank
PE 13.1
Fwd PE 12.49
P/S 0.55
P/FCF 21.79
P/OCF 17.02
P/B 2.37
P/tB 103.55
EV/EBITDA 11.41
EPS(TTM)29.02
EY7.63%
EPS(NY)30.42
Fwd EY8%
FCF(TTM)17.44
FCFY4.59%
OCF(TTM)22.33
OCFY5.87%
SpS687.5
BVpS160.65
TBVpS3.67
PEG (NY)2.72
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 14.47%
ROCE 8.55%
ROIC 6.52%
ROICexc 7.07%
ROICexgc 13.34%
OM 5.18%
PM (TTM) 3.38%
GM N/A
FCFM 2.54%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.96
Debt/EBITDA 2.8
Cap/Depr 90.17%
Cap/Sales 0.71%
Interest Coverage 7.39
Cash Conversion 54.43%
Profit Quality 75.02%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC7.89%
ROIC/WACC0.83
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
EPS Next Y4.82%
EPS Next 2Y9.47%
EPS Next 3Y11.73%
EPS Next 5Y12.36%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.49%
Revenue Next Year10.19%
Revenue Next 2Y8.79%
Revenue Next 3Y8.77%
Revenue Next 5Y7.14%
EBIT growth 1Y-3.59%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year10.19%
EBIT Next 3Y10.57%
EBIT Next 5Y11.36%
FCF growth 1Y-33.69%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-28.77%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%